Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,792 | 300 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $826.15 | 68 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $572.54 | 40 | $0 (2024) |
| Alkermes, Inc. | $532.56 | 59 | $0 (2024) |
| ITI, Inc. | $328.59 | 18 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $312.39 | 24 | $0 (2024) |
| Lundbeck LLC | $240.69 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $216.11 | 21 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $190.44 | 9 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $172.49 | 12 | $0 (2024) |
| Corium, LLC | $120.31 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,203 | 81 | ABBVIE INC. ($287.87) |
| 2023 | $1,233 | 91 | ABBVIE INC. ($354.90) |
| 2022 | $1,356 | 128 | Alkermes, Inc. ($259.14) |
All Payment Transactions
300 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: CNS | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/07/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: CNS | ||||||
| 10/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: CNS | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Neuropsychiatry | ||||||
| 10/01/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Neuroscience | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Central Nervous System | ||||||
| 09/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 109 | 210 | $48,552 | $13,260 |
| 2022 | 2 | 70 | 101 | $25,062 | $9,734 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 109 | $25,913 | $7,089 | 27.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 31 | 72 | $12,240 | $3,952 | 32.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 18 | 18 | $6,714 | $1,124 | 16.7% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 11 | 11 | $3,685 | $1,095 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 62 | $13,362 | $4,876 | 36.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 39 | 39 | $11,700 | $4,858 | 41.5% |
About Janice Cunningham, APRN
Janice Cunningham, APRN is a Nurse Practitioner healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2012. The National Provider Identifier (NPI) number assigned to this provider is 1700151651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Janice Cunningham, APRN has received a total of $3,792 in payments from pharmaceutical and medical device companies, with $1,203 received in 2024. These payments were reported across 300 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,792).
As a Medicare-enrolled provider, Cunningham has provided services to 179 Medicare beneficiaries, totaling 311 services with total Medicare billing of $22,994. Data is available for 2 years (2022–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Lincoln, NE
- Active Since 03/11/2012
- Last Updated 03/11/2012
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1700151651
Products in Payments
- VRAYLAR (Drug) $826.15
- REXULTI (Drug) $600.20
- CAPLYTA (Drug) $519.03
- ARISTADA (Drug) $509.42
- INVEGA SUSTENNA (Drug) $216.11
- INGREZZA (Drug) $172.49
- AUSTEDO (Drug) $150.32
- ABILIFY MAINTENA (Drug) $141.95
- Austedo XR (Drug) $130.82
- Auvelity (Drug) $95.78
- ABILIFY ASIMTUFII (Drug) $71.08
- AZSTARYS (Drug) $64.37
- Azstarys (Drug) $55.94
- JORNAY PM (Drug) $44.98
- TRINTELLIX (Drug) $35.79
- LATUDA (Drug) $35.15
- HETLIOZ (Drug) $34.94
- UZEDY (Drug) $31.25
- LYBALVI (Drug) $23.14
- COBENFY (Drug) $19.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Lincoln
Dr. Linda Young, Aprn Bc, Dnp, APRN BC, DNP
Nurse Practitioner — Payments: $8,072
Jenna Beideck, Aprn, APRN
Nurse Practitioner — Payments: $7,562
Kelley Hanau, Aprn, APRN
Nurse Practitioner — Payments: $6,233
Ms. Rebecca Steinhour, Pmhnp-Bc, Msn, Aprn-, PMHNP-BC, MSN, APRN-
Nurse Practitioner — Payments: $5,762
Natalie Neifert
Nurse Practitioner — Payments: $3,939
Breann Miller, Aprn, APRN
Nurse Practitioner — Payments: $3,894